- Indonesiya ta amince da rigakafin coronavirus da Rasha ta yi.
- An gudanar da cikakken nazari akan magungunan.
- Ya zuwa yanzu Indonesia ta sami fiye da 4,000,000 na COVID-19.
Hukumar Kula da Magunguna da Kula da Abinci ta Indonesiya ta sanar a ranar Laraba cewa an amince da rigakafin cutar coronavirus da Rasha ta yi na Sputnik V don amfani da gaggawa a cikin kasar.
"Hukumar Kula da Magunguna da Abinci ta kasa ta amince da wani maganin coronavirus, Sputnik V, a ranar Talata, 24 ga Agusta," sanarwar da aka buga a yau a shafin yanar gizon kasar. Hukumar Kula da Magunguna da Abinci ta Kasa karanta.
Shugabar hukumar Penny Lukito ta ce an gudanar da cikakken nazari kan magungunan. Ta kara da cewa tasirin Sputnik V ya tsaya a 91.6%.
Asusun saka hannun jari na Rasha kai tsaye (RDIF), ta kuma ce Indonesia ce kasa ta 70 da ta amince Sputnik v. Jimlar yawan ƙasashen da suka ba da izinin rigakafin Rasha biliyan huɗu ne, wanda ke da kashi 50% na al'ummar duniya.
"Indonesia tana ɗaya daga cikin ƙasashe mafi yawan jama'a a Asiya kuma haɗawar Sputnik V a cikin kundin rigakafin rigakafi na ƙasa zai samar da yin amfani da ɗayan mafi aminci kuma mafi inganci a duniya," in ji Shugaba na RDIF.
Ya zuwa yanzu Indonesia ta sami fiye da miliyan huɗu da suka kamu da cutar coronavirus, sama da mutuwar 128,000 kuma kusan miliyan 3.6 sun murmure. Hukumomin kasar tun da farko sun amince da amfani da allurar rigakafin coronavirus da Sinovac, Sinopharm, AstraZeneca, Moderna da Pfizer suka samar.
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- “Indonesia is one the most populated nations in Asia and inclusion of Sputnik V in the national vaccine portfolio will provide for using one of the safest and most effective vaccines in the world,”.
- Indonesia's National Agency of Drug and Food Control announced on Wednesday that the Russian-made Sputnik V coronavirus vaccine has been approved for emergency use in the country.
- The Russian Direct Investment Fund (RDIF), in turn, said that Indonesia was the 70th country to approve Sputnik V.
